Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Esophageal cancer patients may avoid surgery after promising initial therapy

NCT ID NCT07162506

First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 28 times

Summary

This study looks at two different treatments for people with a type of esophageal cancer that shrank after initial drug therapy. Half the participants will have surgery to remove the tumor, while the other half will get radiation and more chemo instead. The goal is to see if avoiding surgery is just as effective and helps preserve the esophagus. All participants will continue on a maintenance drug for up to a year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tianjin Cancer Hospital

    RECRUITING

    Tianjin, Tianjin Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.